CDT Equity Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
3.110
-0.310 (-9.06%)
At close: Aug 10, 2026, 4:00 PM EDT
3.190
+0.080 (2.57%)
After-hours: Aug 10, 2026, 7:53 PM EDT
CDT Equity Market Cap
CDT Equity has a market cap or net worth of $1.96 million as of August 10, 2026. Its market cap has decreased by -63.72% in one year.
Market Cap
1.96M
Enterprise Value
2.72M
1-Year Change
-63.72%
Ranking
Category
Stock Price
$3.11
ChartMarket Cap Chart
Since March 28, 2022, CDT Equity's market cap has decreased from $149.11M to $1.96M, a decrease of -98.68%. That is a compound annual growth rate of -62.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 1.96M | -5.89% |
| Dec 31, 2025 | 2.09M | -74.02% |
| Dec 31, 2024 | 8.03M | -97.55% |
| Dec 29, 2023 | 327.63M | 113.07% |
| Dec 30, 2022 | 153.77M | 3.12% |
| Mar 28, 2022 | 149.11M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GRI Bio | 2.60M |
| Artelo Biosciences | 2.51M |
| Oragenics | 2.48M |
| Clearmind Medicine | 2.42M |
| Virax Biolabs Group | 2.38M |
| Azitra | 2.19M |
| Moleculin Biotech | 2.19M |
| Decoy Therapeutics | 2.09M |